This may suggest that, in ER+ breast cancers, Mcl-1 plays a dominant role among Bcl-2 family members under conditions in which an imbalance of pro- and anti-apoptotic factors threaten cell survival. This evidence concerns the gene MCL1 and breast carcinoma.